Close Menu

NEW YORK (GenomeWeb) – Researchers at the University of Illinois Urbana-Champaign, the Mayo Clinic, and the Medical College of Wisconsin are developing a diagnostic platform intended for single-molecule imaging of microRNA directly from a single drop of blood.

The technology will be initially applied to metastatic prostate cancer, where fluctuating miRNA levels have been shown to correlate with response to treatment, with a long-term goal of creating a device that can be used by patients for at-home monitoring.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.